on 15 Dec 2020
Last Applicant/ Owned by
Har Hotzvim
Jerusalem
IL
91010
Serial Number
87352575 filed on 28th Feb 2017
Registration Number
6222131 registered on 15th Dec 2020
Correspondent Address
Laurence Rickles
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
The mark consists of a line design that begins at the bottom center and rises up to the center right side. In the bottom right hand corner is the word TEVA with the letter v formed by 2 leaf shapes. Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the preRead More
Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system
21st Sep 2020
21st Sep 2020
No 87352575
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
05.03.08 -
More than one leaf, including scattered leaves, bunches of leaves not attached to branches
26.17.06 -
Diagonal line(s), band(s) or bar(s)
26.17.09 -
Curved line(s), band(s) or bar(s)
27.03.04 -
Representations of plants or parts of plants forming letters or numerals, including punctuation
The mark consists of a line design that begins at the bottom center and rises up to the center right side. In the bottom right hand corner is the word TEVA with the letter v formed by 2 leaf shapes.
| Status Date | Action Taken |
|---|---|
| 15th Dec 2020 | REGISTERED-PRINCIPAL REGISTER |
| 10th Nov 2020 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 09th Nov 2020 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 05th Nov 2020 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 05th Nov 2020 | SU-EXAMINER'S AMENDMENT WRITTEN |
| 05th Nov 2020 | EXAMINER'S AMENDMENT ENTERED |
| 05th Nov 2020 | EXAMINERS AMENDMENT E-MAILED |
| 30th Oct 2020 | STATEMENT OF USE PROCESSING COMPLETE |
| 20th Oct 2020 | USE AMENDMENT FILED |
| 20th Oct 2020 | TEAS STATEMENT OF USE RECEIVED |
